Skip to main content
SpringerLink
Log in

Cancers cutanés après transplantation d’organe

  • Chapter
Manifestations dermatologiques des maladies du système hématopoïétique et oncologie dermatologique

  • 459 Accesses

Abstrait

La population des greffés d’organe ne cesse de croître en raison d’un allongement régulier de leur survie àlong terme. Il existe maintenant de nombreux patients vivant depuis plus de 20 ans grâce àun greffon, la survie des plus anciens approchant 18, 27 et 40 ans après greffe hépatique, cardiaque et rénale, respectivement. Le bon fonctionnement du greffon nécessite la prise d’un traitement immunosuppresseur àvie induisant une nette augmentation du risque de cancers parmi lesquels les carcinomes cutanés sont les plus fréquents. Ils consistent en carcinomes cutanés (95% des cas), mais aussi en tumeurs variées telles la maladie de Kaposi, le mélanome, les cancers anogénitaux et d’autres tumeurs plus rares comme le carcinome àcellules de Merkel ou le fibroxanthome atypique.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Kasiske BL, Snyder JJ, Gilbertson DT et al. Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4:905–913.

    Article  PubMed  Google Scholar 

  2. Buell J, Gross TG, Woodle S. Malignancy after transplantation. Transplantation 2005; 80: S254–S264.

    Article  PubMed  Google Scholar 

  3. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348:1681–1691.

    Article  PubMed  Google Scholar 

  4. Bouwes-Bavinck JN, Hardie D, Green A et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. Transplantation 1996; 61:715–721.

    Article  PubMed  CAS  Google Scholar 

  5. Naldi L, Fortina AB, Lovati S et al. Risk of nonmelanoma skin cancer in Italian organ transplant recipients. A registry-based study. Transplantation 2000; 70(10):1479.

    Article  PubMed  CAS  Google Scholar 

  6. Harden PN, Fryer AA, Reece S et al. Annual incidence and predicted risk of nonmelanoma skin cancer in renal transplant recipients. Transplant Proc 2001; 33:1302–1304.

    Article  PubMed  CAS  Google Scholar 

  7. Ramsay HM, Fryer AA, Hawley CM et al. Non melanoma skin cancer risk in the Queensland renal transplant population. Br J Dermatol 2002; 147:950–956.

    Article  PubMed  CAS  Google Scholar 

  8. Bordea C, Wojnarowska F, Millard PR et al. Skin cancers in renal-transplant recipients occur more frequently than previously recognized in a temperate climate. Transplantation 2004; 77:574–579.

    Article  PubMed  CAS  Google Scholar 

  9. Fuente MJ, Sabat M, Roca J et al. A prospective study of the incidence of skin cancer and its risk factors in a Spanish Mediterranean population of kidney transplant recipients. Br J Dermatol 2003; 149:1221–1226.

    Article  PubMed  CAS  Google Scholar 

  10. Euvrard S, Kanitakis J, Deadlier E et al. Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma. Transplantation 2006; 81:1093–1100.

    Article  PubMed  Google Scholar 

  11. Euvrard S, Kanitakis J, Cochat P et al. Skin cancers following pediatrie organ transplantation. Dermatol Surg 2004; 30:616–621.

    Article  PubMed  Google Scholar 

  12. Euvrard S, Kanitakis J, Pouteil-Noble C et al. Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol 1995; 33:222–229.

    Article  PubMed  CAS  Google Scholar 

  13. Lindelöf B, Dal H, Wolk K et al. Cutaneous squamous cell carcinoma in organ transplant recipients: a study of the Swedish cohort with regard to tumor site. Arch Dermatol 2005; 141: 447–451.

    Article  PubMed  Google Scholar 

  14. Lindelöf B, Sigurgeirsson B, Gäbel H et al. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000; 143:513–519.

    PubMed  Google Scholar 

  15. Cooper SM, Wojnarowska F. The accuracy of clinical diagnosis of suspected premalignant and malignant skin lesions in renal transplant recipients. Clin Exp Dermato 2002; 27:436–438.

    Article  CAS  Google Scholar 

  16. Euvrard S, Kanitakis J, Pouteil-Noble C etal. Aggressive squamous cell carcinomas in organ transplant recipients. Transplant Proc 1995; 27: 1767–1768.

    PubMed  CAS  Google Scholar 

  17. Adamson R, Obispo E, Dychter S et al. High incidence and clinical course of aggressive skin cancer in heart transplant patients: a singlecenter study. Transplant Proc 1998; 30:1124–1126.

    Article  PubMed  CAS  Google Scholar 

  18. Veness MJ, Quinn DI, Ong CS etal. Aggressive cutaneous malignancies following cardiothoracic transplantation. Cancer 1999; 85:1759–1764.

    Article  Google Scholar 

  19. Martinez JC, Otley CC, Stasko T et al. Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study. Arch Dermatol 2003; 139: 301–306.

    Article  PubMed  Google Scholar 

  20. Harwood CA, Proby CM, McGregor JM et al. Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series. J Am Acad Dermatol 2006; 54:290–300.

    Article  PubMed  Google Scholar 

  21. Kanitakis J, Alhaj-lbrahim L et al. Basal cell carcinomas developing in solid organ transplant recipients: clinicopathologic study of 176 cases. Arch Dermatol 2003; 139:1133–1137.

    Article  PubMed  Google Scholar 

  22. Ramsay HM, Fryer AA, Hawley CM et al. Factors associated with nonmelanoma skin cancer following renal transplantation in Queensland, Australia. J Am Acad Dermatol 2003; 49: 397–406.

    Article  PubMed  Google Scholar 

  23. Ong CS, Keogh AM, Kossard S et al. Skin cancer in Australian heart transplant recipients. J Am Acad Dermatol 1999; 40:27–34.

    Article  PubMed  CAS  Google Scholar 

  24. Otley CC, Coldiron BM, Stasko T et al. Decreased skin cancer after cessation of therapy with transplant-associated immunosuppressants. Arch Dermatol 2001; 137:459–463.

    PubMed  CAS  Google Scholar 

  25. Berg D, Otley C. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002; 47:1–17.

    Article  PubMed  Google Scholar 

  26. Otley CC, Maragh SL. Reduction of immunosuppression for transplant-associated skin cancer: rationale and evidence of efficacy. Dermatol Surg 2005; 31:163–168.

    PubMed  CAS  Google Scholar 

  27. Otley C, Berg D, Ulrich C et al. Reduction, of immunosuppression for transplant-associated skin cancer: expert consensus survey. Br J Dermatol 2006; 154:395–400.

    Article  PubMed  CAS  Google Scholar 

  28. Ducloux D, Carron PL, Rebibou JM et al. CD4 lymphopenia as a risk factor for skin cancers in renal transplant recipients. Transplantation 1998; 65:1270–1272.

    Article  PubMed  CAS  Google Scholar 

  29. Jensen P, Hansen S, Moller B et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999; 40:177–186.

    Article  PubMed  CAS  Google Scholar 

  30. Glover MT, Deeks JJ, raftery MJ et al. Immunosuppression and risk of non-melanoma skin cancer in renal transplant recipiënt. Lancet 1997; 349:398.

    Article  PubMed  CAS  Google Scholar 

  31. Dantal J, Hourmant M, Cantarovich D et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet 1998; 351:623–628.

    Article  PubMed  CAS  Google Scholar 

  32. Caforio AL, Fortina AB, Piaserico S et al. Skin cancer in heart transplant recipients: risk factor analysis and relevance of immunosuppressive therapy. Circulation 2000; 102:222–227.

    Google Scholar 

  33. Guba M, Graeb C, Jauch KW et al. Proand anti-cancer effects of immunosuppressive agents used in organ transplantation. Transplantation 2004; 77:1777–1782.

    Article  PubMed  CAS  Google Scholar 

  34. Hojo M, Morimoto T, Malucio M et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 1999; 397: 530–534.

    Article  PubMed  CAS  Google Scholar 

  35. Malucio M, Sharma V, Lagman M et al. Tacrolimus enhances transforming growth factor-betal expression and promotes tumor progression. Transplantation 2003; 76:597–602.

    Article  CAS  Google Scholar 

  36. Mohamed MA, Robertson H, Booth TA et al. TGF-beta expression in renal transplant biopsies: a comparative study between cyclosporin-A and tacrolimus. Transplantation 2000; 69: 1002–1005.

    Article  PubMed  CAS  Google Scholar 

  37. O’Donovan P, Perrett CM, Zhang X et al. Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 2005; 309: 1871–1874.

    Article  PubMed  CAS  Google Scholar 

  38. Harwood CA, Surentheran T, McGregor JM et al. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 2000; 61:289–297.

    Article  PubMed  CAS  Google Scholar 

  39. Bouwes Bavinck JN, Feltkampf M et al. Human papillomavirus infection and skin cancer risk in organ transplant recipients. J Invest Dermatol Symp Proceed 2001; 6:207–211.

    Article  Google Scholar 

  40. Joly P, Bastuji-Garin S, Francès C et al. Relation entre la presence de verrues et la survenue de carcinomas épidermoïdes cutanés chez les transplantés d’organe. Ann Dermatol Venereol 2005;132:9S32.

    Google Scholar 

  41. De Jong-Tieben LM, Berkhout R et al. The prevalence of human papillomavirus DNA in benign keratotic skin lesions of renal transplant recipients with and without a history of skin cancer is equally high: a clinical study to assess risk factors for keratotic skin lesions and skin cancer. Transplantation 2000; 69:44–49.

    Article  PubMed  Google Scholar 

  42. Boxman ILA, Berkhout RJM, Mulder LHC et al. Detection of Human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol 1997; 108:712–715.

    Article  PubMed  CAS  Google Scholar 

  43. Berkhout R, Bouwes-Bavinck J, Schegget J. Persistence of Human Papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients. J Clin Microbiol 2000; 38:2087–2096.

    PubMed  CAS  Google Scholar 

  44. Hiesse C, Rieu P, Kriaa F et al. Malignancy after renal transplantation: analysis of incidence and risk factors in 1700 patients followed during a 25-year period. Transplant Proc 1997; 29:831–833.

    Article  PubMed  CAS  Google Scholar 

  45. De Hertog SA, Wensveen CA, Bastiaens MT et al. Relation between smoking and skin cancer. J Clin Oncol 2001; 19:231–238.

    PubMed  Google Scholar 

  46. Ramsay HM, Harden PN, Reece S et al. Polymorphism in glutathione S-transferases are associated with altered risk of nonmelanoma skin cancer in renal transplant recipients: a preliminary analysis. J Invest Dermatol 2002; 117:251–255.

    Article  Google Scholar 

  47. Marshall SE, Bordea C, Wojnarowska F et al. P53 codon 72 polymorphism and susceptibility to skin cancer after renal transplantation. Transplantation 2000; 69:994–996.

    Article  PubMed  CAS  Google Scholar 

  48. Storey A, Thomas M, Kalita A et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 1998; 393:229–234.

    Article  PubMed  CAS  Google Scholar 

  49. Cairey-Remonnay S, Humbey O, Mougin C et al. TP 53 polymorphism of exon 4 at codon 72 in cutaneous squamous cell carcinoma and benign epithelial lesions of renal transplant recipients and immunocompetent individuals: lack of correlation with HPV status. J Invest Dermatol 2002; 118:1026–1031.

    Article  PubMed  CAS  Google Scholar 

  50. McGregor JM, Harwood CA, Brooks L et al. Relationship between p53 Codon 72 polymorphism and susceptibility to sunburn and skin cancer. J Invest Dermatol 2002; 119:84–90.

    Article  PubMed  CAS  Google Scholar 

  51. Marshall SE, Bordea C, Haldar N et al. Glutathione S-transferase polymorphisms and skin cancer after renal transplantation. Kidney Int 2000; 58:2186–2193.

    Article  PubMed  CAS  Google Scholar 

  52. Alamartine E, Berthoux P, Mariat C et al. Interleukin-10 Promoter Polymorphisms and susceptibility to skin squamous cell carcinoma after renal transplantation. J Invest Dermatol 2003; 120:99–103.

    Article  PubMed  Google Scholar 

  53. Bouwes-Bavinck JN, Claas F, Hardie D et al. Relation between HLA antigens and skin cancer in renal transplant recipients in Queensland, Australia. J Invest Dermatol 1997; 108: 708–711.

    Article  PubMed  CAS  Google Scholar 

  54. O’Connor DP, Kay EW, Leader M et al. A high degree of chromosomal instability at 13q14 in cutaneous squamous cell carcinomas: indication for a role of a tumour suppressor gene other than Rb. Mol Pathol 2001; 54:165–169.

    Article  PubMed  Google Scholar 

  55. Aractingi S, Kanitakis J, Euvrard S et al. Skin carcinoma arising from donor cells in a kidney transplant recipient. Cancer Res 2005; 65:1755–1760.

    Article  PubMed  CAS  Google Scholar 

  56. Fortina AB, Caforio AL, Piaserico S et al. Skin cancer in heart transplant recipients: frequency and risk factor analysis. J Heart Lung Transplant 2000; 19:249–255.

    Article  PubMed  CAS  Google Scholar 

  57. Euvrad S, Kanitakis J. Skin cancers after liver transplantation: What to do ? J Hepatol 2006; 44:27–32.

    Article  Google Scholar 

  58. Otley C, Cherikh WS, Salsche SJ et al. Skin cancer in organ transplant recipients: effect of pretransplant end-organ disease. J Am Acad Dermatol 2005; 53:783–790.

    Article  PubMed  Google Scholar 

  59. Stasko T, Brown MD, Carucci JA et al. Guidelines for the management of squamous cell carcinoma in organ transplant recipients. Dermatol Surg 2004; 30:642–650.

    Article  PubMed  Google Scholar 

  60. Stockfleth E, Ulrich C, Meyer T et al. Epithelial malignancies in organ transplant patients: clinical presentation and new methods of treatment. Recent Results Cancer Res 2002; 160:251–258.

    PubMed  CAS  Google Scholar 

  61. Vidal D, Alomar A. Efficacy of imiquimod 5 % cream for basal cell carcinoma. Clin Exp Dermatol 2004; 29:237–239.

    Article  PubMed  CAS  Google Scholar 

  62. Bradley TK, Stasko T. Use of topical immunomodulators in organ transplant recipients. Dermatol Therapy 2005; 18:19–27.

    Article  Google Scholar 

  63. Brown VL, Atkins CL, Ghali L et al. Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial. Arch Dermatol 2005; 141:985–993.

    Article  PubMed  CAS  Google Scholar 

  64. Dragieva G, Hafner J, Dummer R et al. Topical photodynamic therapy in the treatment of actinic kératoses and Bowen’s disease in transplant recipients. Transplantation 2004; 77:115–121.

    Article  PubMed  Google Scholar 

  65. De Graaf YG, Kennedy C, Wolterbeek R et al. Photodynamic therapy does not prevent cutaneous squamous cell carcinoma in organ transplant recipients: results of a randomized-controlled trial. J Invest Dermatol 2006; 126: 569–574.

    Article  PubMed  CAS  Google Scholar 

  66. Perret CM, Tan SK, Cerio P et al. Treatment of basal cell carcinoma with topical methylaminolaevulinate photodynamic therapy in an organ transplant recipient. Clin Exp Dermatol 2005; 31:146–147.

    Article  Google Scholar 

  67. Bouwes Bavinck JN, Tieben LM, Van der Woude FJ et al. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients, a double-blind, placebo-controlled study. J Clin Oncol 1995; 13:1933–1938.

    Google Scholar 

  68. De Graaf YG, Euvrard S, Bowes Bavinck JN. Systemic and topical retinoids in the management of skin cancer in organ transplant recipients. Dermatol Surg 2004; 30:656–661.

    Article  PubMed  Google Scholar 

  69. Martinez JC, Otley CC, Euvrard S et al. International Transplant-Skin Cancer Collaborative. Complications of systemic retinoid therapy in organ transplant recipients with squamous cell carcinoma. Dermatol Surg 2004; 30: 662–666.

    Article  PubMed  Google Scholar 

  70. McKenna DB, Murphy GM. Skin cancer chemoprophylaxis in renal transplant récipients: 5 years of experience using low-dose acitretin. Br J Dermatol 1999; 140:656–660.

    Article  PubMed  CAS  Google Scholar 

  71. De Sevaux RGL, Smit JV, de Jong EM et al. Acitretin treatment of premalignant and malignant skin disorders in renal transplant recipients: clinical effects of a randomized trial comparing two doses of acitretin. J Am Acad Dermatol 2003; 49:407–412.

    Article  PubMed  Google Scholar 

  72. Harwood CA, Leedham-Greden M, Leigh I et al. Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study. Arch Dermatol 2005; 141:456–464.

    Article  PubMed  CAS  Google Scholar 

  73. Rook AH, Jaworsky C, Nguyen T et al. Beneficial effect of low-dose systemic retinoid in combination with topical tretinoin for the treatment and prophylaxis of premalignant and malignant skin lesions in renal transplant recipients. Transplantation 1995; 59:714–719.

    Article  PubMed  CAS  Google Scholar 

  74. Euvrard S, Ulrich C, Lefrançois N. Immunosuppressants and skin cancer in transplant patients: focus on rapamycin. Dermatol Surg 2004; 30:628–633.

    Article  PubMed  Google Scholar 

  75. Mathew T, Kreis H, Friend R Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies. Clin Transplant 2004; 18:446–449.

    Article  PubMed  Google Scholar 

  76. Kahan BD, Yakupoglu YK, Schoenberg L et al. Low incidence of malignancy among sirolimus: cydosporine-treated renal transplant recipients. Transplantation 2005; 80:749–758.

    Article  PubMed  CAS  Google Scholar 

  77. Kauffman HM, Cherikh WS, Cheng Y et al. Maintenance Immunosuppression with Target-of-Rapamycin Inhibitors is Associated with a Reduced Incidence of De Novo Malignancies. Transplantation 2005; 80:883–889.

    Google Scholar 

  78. Campistol J, Eris J, Oberbauer R et al. Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation. J Am Soc Nephrol 2006; 17:581–589.

    Article  PubMed  CAS  Google Scholar 

  79. Morelon E, Kreis H. Sirolimus therapy without calcineurin inhibitor: Necker Hospital 8-year experience. Transplant Proc 2003; 35:52 S 57S.

    Google Scholar 

  80. Mahe E, Morelon E, Lechaton S et al. Cutaneous adverse events in renal transplant recipients receiving sirolimus-based therapy. Transplantation 2005; 79:476–482.

    Article  PubMed  CAS  Google Scholar 

  81. Izzedine H, Brocheriou I, Frances C. Posttransplantation proteinuria and sirolimus. N Engl J Med 2005; 353:2088–2089.

    Article  PubMed  CAS  Google Scholar 

  82. Butt A, Roberts DL. Renal transplant recipients and protection from sun; need for education (letter). Lancet 1997; 349:179–180.

    Article  PubMed  CAS  Google Scholar 

  83. Cowen EW, Billingsley EM. Awareness of skin cancer by kidney transplant patients. J Am Acad Dermatol 1999; 40:697–701.

    Article  PubMed  CAS  Google Scholar 

  84. Donovan JCH, Rosen CF, Shaw JC. Evaluation of sun-protective practices of organ transplant recipients. Am J Transplant 2004; 4:1852–1858.

    Article  PubMed  Google Scholar 

  85. Mahe E, Morelon E, Fermanian J et al. Renal-transplant recipients and sun protection. Transplantation 2004; 78:741–744.

    PubMed  Google Scholar 

  86. Moloney FJ, Almarzouqi, O’Kelly P et al. Sunscreen use before and after transplantation and assessment of risk factors associated with skin cancer development in renal transplant recipients. Arch Dermatol 2005; 141:978–982.

    Article  PubMed  Google Scholar 

  87. Szepietowski JC, Reich A, Nowicka D et al. Sun protection in renal transplant recipients: urgent need for education. Dermatology 2005; 211:93–97.

    Article  PubMed  Google Scholar 

  88. Penn I. Cancers of the anogenital region in renal transplant recipients. Cancer 1986; 58: 611–616.

    Article  PubMed  CAS  Google Scholar 

  89. Birkeland S, Storm HH, Lamm LU et al. Cancer risk after renal transplantation in Nordic countries. Int J Cancer 1995; 60:183–189.

    Article  PubMed  CAS  Google Scholar 

  90. Euvrard S, Kanitakis J, Chardonnet Y et al. External anogenital lesions in organ transplant recipients. Arch Dermatol 1997; 133:175–178.

    Article  PubMed  CAS  Google Scholar 

  91. Sillman FH, Sentovich S, Shaffer D. Anogenital neoplasia in renal transplant patients. Ann Transplant 1997; 2:59–66.

    PubMed  CAS  Google Scholar 

  92. Serraino D, Angeletti C, Carrieri MP et al. Kaposi’s sarcoma in transplant and HIV-infected patients: an epidemiologic study in Italy and France. Transplantation 2005; 80: 1699–1704.

    Article  PubMed  Google Scholar 

  93. Ozen S, Saatci U, Karaduman A et al. Kaposi’s sarcoma in a paediatric renal transplant recipient. Nephrol Dial Transplant 1996; 11: 1162–1163.

    PubMed  CAS  Google Scholar 

  94. Allen U. Human herpesvirus type 8 infections among solid organ transplant recipients. Pediatr Transplantation 2002; 6:187–192.

    Article  Google Scholar 

  95. Cattaneo D, Gotti E, Perico N et al. Cyclosporine formulation and Kaposi’s sarcoma after renal transplantation. Transplantation 2005; 80:743–748.

    Article  PubMed  CAS  Google Scholar 

  96. Besnard V, Euvrard S, Kanitakis J et al. Kaposi’s sarcoma after liver transplantation. Dermatology 1996; 193:100–104.

    Article  PubMed  CAS  Google Scholar 

  97. Becuwe C, Euvrard S, Bosshard S et al. Kaposi’s sarcoma and organ transplantation: 22 cases. Ann Dermatol Venereol 2005; 132:839–843.

    Article  PubMed  CAS  Google Scholar 

  98. Farge D. Kaposi’s sarcoma in organ transplant recipients. Eur J Med 1993; 2:339–343.

    PubMed  CAS  Google Scholar 

  99. Pellet C, Chevret S, Francès C et al. Prognostic value of quantitative Kaposi sarcoma-associated Herpesvirus load in posttransplantation Kaposi sarcoma. J Infect Dis 2002; 186: 110–113.

    Article  PubMed  Google Scholar 

  100. Cattani P, Cerimele F, Porta D et al. Age-specific seroprevalence of human herepesvirus 8 in Mediterranean regions. Clin Microbiol Infect 2003; 4:274–279.

    Article  Google Scholar 

  101. Francès C, Mouquet C, Marcellin AG et al. Outcome of kidney transplant recipients with previous human herpevirus-8 infection. Transplantation 2000; 69:1776–1779.

    Article  PubMed  Google Scholar 

  102. Emond JR, Marcelin AG, Dorent R et al. Kaposi’s sarcoma associated with previous human herpes virus 8 infection in heart transplant recipients. J Clin Microhiol 2002; 40:2217–2219.

    Article  Google Scholar 

  103. Cattani P, Capuano M, Graffeo R et al. Kaposi’s sarcoma associated with previous human herpes virus 8 infection in kidney transplant recipients. J Clin Microhiol 2001; 39:506–508.

    Article  CAS  Google Scholar 

  104. Regamey N, Tamm M, Wernli M et al. Transmission of Human herpesvirus 8 infection from renal-transplant donors to recipients. N Engl J Med 1998; 339:1358–1363.

    Article  PubMed  CAS  Google Scholar 

  105. Barozzi P, Luppi M, Facchetti F et al. Post-transplant Kaposi’s sarcoma originates from the seeding of donor-derived progenitors. Nature Medicine 2003; 9:554–561.

    Article  PubMed  CAS  Google Scholar 

  106. Francès C, Lebbe C. Maladie de Kaposi du transplanté d’organe: faut-il prévenir, stabiliser ou tenter de guérir? Ann Dermatol Venereol 2005; 132:839–843.

    Article  Google Scholar 

  107. Milliancourt C, Barete S, Marcelin AG et al. Human herpesvirus-8 seroconversions after renal transplantation. Transplantation 2001; 72: 1319–1320.

    Article  PubMed  CAS  Google Scholar 

  108. Luppi M, Barozzi P, Rasini V et al. Severe pancytopenia and hemophagocytosis after HHV-8 primary infection in a renal transplant patient successfully treated with foscarnet. Transplantation 2002; 74:131–132.

    Article  PubMed  Google Scholar 

  109. Marcelin AG, Roque-Afonso AM, Hurtova M et al. Fatal disseminated Kaposi’s sarcoma fol-lowing human herpesvirus 8 primary infections liver transplant recipients. Liver Transpl 2004; 10:295–300.

    Article  PubMed  Google Scholar 

  110. Kanitakis J, Narvaez D, Claudy A. Expression of the CD34 antigen distinguishes Kaposi’s sarcoma from pseudo Kaposi’s sarcoma (acroan-giodermatitis). Br J Dermatol 1996; 134:44–46.

    Article  PubMed  CAS  Google Scholar 

  111. Barete S, Calvez V, Mouquet C et al. Clinical features and contribution of virological findings to the management of Kaposi sarcoma in organ-allograft recipients. Arch Dermatol 2000; 136:1452–1458.

    Article  PubMed  CAS  Google Scholar 

  112. Gomez E, Aguado S, Rodriguez M et al. Kaposi’s sarcoma after renal transplantation-disappearance after reduction of immunosup-pression and reappearance 7 years later after start of mycophenolate mofetil treatment. Nephrol Dial Transplant 1998; 13:3279–3280.

    Article  PubMed  CAS  Google Scholar 

  113. Doutrelepont JM, De Pauw L, Gruber SA et al. Renal transplantation exposes patients with previous Kaposi’s sarcoma to a high risk of recurrence. Transplantation 1996; 62:463–466.

    Article  PubMed  CAS  Google Scholar 

  114. Woodle ES, Hanaway M, Buell J et al. Kaposi’s sarcoma: an analysis of the US and International experiences from the Israel Perm International Transplant Registry. Transplant Proc 2001; 33:3360–3361.

    Google Scholar 

  115. Campistol JM, Gutierrez-Dalmau A, Torregrosa JV. Conversion to sirolimus: a successful treatment for posttransplantation Kaposi’s sarcoma. Transplantation 2004; 77:760–762.

    Article  PubMed  Google Scholar 

  116. Stallone G, Schena A, Infante B et al. Sirolimus for Kaposi’s sarcoma in renal-transplant recipients. N Engl J Med 2005; 352:1317–1323.

    Article  PubMed  CAS  Google Scholar 

  117. Shepherd FA, Maher E, Cardella C et al. Treatment of Kaposi’s sarcoma after solid organ transplantation. J Clin Oncol 1997; 15:2371–7.

    PubMed  CAS  Google Scholar 

  118. Euvrard S, Kanitakis J, Brosshard C et al. No recurrence of posttransplant Kaposi’s sarcoma three years after a second renal transplantation. Transplantation 2002; 73:297–299.

    Article  PubMed  Google Scholar 

  119. Lévêque L, Dalac S, Dompmartin A et al. Mélanome chez le transplanté. Ann Dermatol Venereal 2000; 127:160–165.

    Google Scholar 

  120. Hollenbeak CS, Todd MM, Billingsley EM et al. Increased incidence of melanoma in renal transplantation recipients. Cancer 2005; 104: 1962–1967.

    Article  PubMed  Google Scholar 

  121. Le Mire L, Hollowood K, Gray D et al. Melanomas in renal transplant recipients. Br J Dermatol 2006; 154:472–477.

    Article  PubMed  Google Scholar 

  122. Penn I. Malignant melanoma in organ allograft recipients. Transplantation 1996; 61:274–278.

    Article  PubMed  CAS  Google Scholar 

  123. Otley CC, Hirose R, Salashe SJ. Skin can cer as a contraindication to organ transplantation. Am J Transplant 2005; 5:2079–2084.

    Article  PubMed  Google Scholar 

  124. Morris-Stiff G, Steel A, Savage P et al. Transmission of donor melanoma to multiple organ transplant recipients. Am J Transplant 2004; 4:444–446.

    Article  PubMed  CAS  Google Scholar 

  125. Penn I, First M. Merkel’s cell carcinoma in organ allograft recipients. Transplantation 1999; 68:1717–1721.

    Article  PubMed  CAS  Google Scholar 

  126. Kanitakis J, Euvrard S, Chouvet B et al. Merkel cell carcinoma in organ transplant recipients: report off two cases with unusual histologial features and literature review. J Cutan Pathol 2006; 33:686–694.

    Article  PubMed  Google Scholar 

  127. Friedlander M, Rubinger D, Rosenbaum E et al. Temporary regression off Merkel cell carcinoma métastases after cessation off cyclosporine. Transplantation 2002; 73:1849–1850.

    Article  Google Scholar 

  128. De Carlis L, Slim A, De Gasperi A et al. Posttransplant lymphoproliferative disorders: report from a single center. Transplantation Proc 2001; 33:2815–2816.

    Article  Google Scholar 

  129. Kapelushnik J, Ariad S, Benharroch D et al. Post renal transplantation human herpesvirus 8-associated lymphoproliferative disorder and Kaposi’s sarcoma. Br J Haematol 2001; 113:425–428.

    Article  PubMed  CAS  Google Scholar 

  130. Euvrard S, Kanitakis J, Claudy A. Neoplastic skin diseases in organ transplant recipients. Am J Cancer 2002; 1:109–120.

    Article  Google Scholar 

  131. Mozzanica N, Cattaneo A, Fracchiolla N et al. Posttransplantation cutaneous B cell lymphoma with monoclonal Epstein-Barr virus infection, responding to acyclovir and reduction in immunosuppression. J Heart Lung Trans-plant 1997; 16:964–968.

    CAS  Google Scholar 

  132. Tas S, Simonart T, Dargent J et al. Granulomatose lymphomatoïde àlocalisation cutanée isolée après une transplantation cardiopulmonaire. Ann Dermatol Venereal 2000; 127: 488–491.

    CAS  Google Scholar 

  133. Beynet DP, Wee SA, Horwitz SS et al. Clinical and pathological fetures off posttransplantation lymphoproliferative disorders presenting with skin involvement in 4 patients. Arch Dermatol 2004; 140:1140–1146.

    Article  PubMed  Google Scholar 

  134. Salama S. Primary «cutaneous» T-cell anaplastic large cell lymphoma, CD30+, neutrophil-rich variant with subcutaneous panniculitic lesions, in a post-renal transplant patient: report off unusual case and literature review. Am J Dermatopathol 2005; 27:217–223.

    Article  PubMed  CAS  Google Scholar 

  135. Carbonnelle A, Mahe E, Morelon E et al. Plasmocytome cutané EBV + isolé chez une malade transplantée rénale: efficacité d’un traitement par rituximab. Ann Dermatol Venereal 2004; 131:1081–1084.

    Article  CAS  Google Scholar 

  136. Buffet M, Dupin N, Carlotti A et al. Plasmocytomes cutanés associés au virus d’Epstein-Barr chez les transplantés d’organes. Ann Dermatol Venereal 2004; 131:1085–1091.

    Article  CAS  Google Scholar 

  137. Euvrard S, Pouteil-Noble C, Kanitakis et al. Successive occurrence of T-cell and B-cell lymphomas after renal transplantation in a patient with multiple cutaneous squamous cell carcinomas. N Engl J Med 1992; 327:1924–1927.

    Article  PubMed  CAS  Google Scholar 

  138. Lok C, Viseux V, Denœux JP et al. Posttransplant cutaneous T cell lymphomas. Crit Rev Oncol Hematol 2005; 56:137–145.

    Article  PubMed  CAS  Google Scholar 

  139. Sierka D, Kumar A, Heifets M et al. Successful minimization of immunosuppression and conversion to sirolimus in kidney transplant recipients with post transplant lymphoproliferative disease and de novo nonskin malignancies [abstract]. Am J Transplantation 2004; S8:523.

    Google Scholar 

  140. Penn I. Sarcomas in organ allograft recipients. Transplantation 1995; 60:1485–1491.

    Article  PubMed  CAS  Google Scholar 

  141. Wehrli B, Janzen D, Shokeir O et al. Epithelioid angiosarcoma arising in surgically constructed arteriovenous fistula. Am J Surg Pathol 1998; 22:1154–1159.

    Article  PubMed  CAS  Google Scholar 

  142. Bessis D, Sotto A, Roubert P et al. Endothelin-secreting angiosarcoma occurring at the site of an arteriovenous fistula for haemodialysis in a renal transplant recipient. Br J Dermatol 1998; 138:361–362.

    Article  PubMed  CAS  Google Scholar 

  143. Farag R, Shulak JA, Abdul-Karim FW et al. Angiosarcoma arising in an arteriovenous fistula site in a renal transplant patient: a case report and literature review. Clin Nephrol 2005; 408–412.

    Google Scholar 

  144. Kanitakis J, Euvrard S, Montazeri A et al. Atypical fibroxanthoma in a renal graft recipient. J Am Acad Dermatol 1996; 35:262–264.

    Article  PubMed  CAS  Google Scholar 

  145. Kovach BT, Sams HH, Stasko T. Multiple atypical fibroxanthomas in a cardiac transplant recipient. Dermatol Surg 2005; 31:467–470.

    PubMed  CAS  Google Scholar 

  146. Lai KN, Lai FM, King WW et al. Dermatofibrosarcoma protuberans in a renal transplant patient. Aust N Z J Surg 1995; 65:900–902.

    Article  PubMed  CAS  Google Scholar 

  147. Picciotto F, Basolo B, Massara C et al. Dermatofibrosarcoma protuberans at the site of arteriovenous fistula in a renal transplant recipient. Transplantation 1999; 68:1074–1075.

    Article  PubMed  CAS  Google Scholar 

  148. Brown VL, Prosby CM, Harwood CA et al. Dermatofibrosarcoma protruberans in a renal transplant recipient. Histopathology 2003; 42: 198–200.

    Article  PubMed  CAS  Google Scholar 

  149. Harwood CA, McGregor JM, Swale VJ et al. High frequency and diversity of cutaneous appendageal tumors in organ transplant recipients. J Am Acad Dermatol 2003; 48:401–408.

    Article  PubMed  Google Scholar 

  150. Otley CC. Organization of a speciality clinic to optimize the care of organ transplant recipients at risk for skin cancer. Dermatol Surg 2000; 26:709–712.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service de Dermatologie, Hôpital Édouard-Herriot, 5 place d’Arsonval, 69437, Lyon CEDEX 03

    Sylvie Euvrard, Jean Kanitakis & Professeur Alain Claudy

Authors
  1. Sylvie Euvrard
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jean Kanitakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Professeur Alain Claudy
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag France, Paris

About this chapter

Cite this chapter

Euvrard, S., Kanitakis, J., Claudy, A. (2009). Cancers cutanés après transplantation d’organe. In: Manifestations dermatologiques des maladies du système hématopoïétique et oncologie dermatologique. Springer, Paris. https://doi.org/10.1007/978-2-287-72092-5_19

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-72092-5_19

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-72091-8

  • Online ISBN: 978-2-287-72092-5

Publish with us

Policies and ethics

Search

Navigation